Faye Feller - Jun 10, 2024 Form 4 Insider Report for GERON CORP (GERN)

Role
EVP, Chief Medical Officer
Signature
/s/ Scott A. Samuels for Faye Feller
Stock symbol
GERN
Transactions as of
Jun 10, 2024
Transactions value $
-$992,436
Form type
4
Date filed
6/12/2024, 04:05 PM
Previous filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GERN Common Stock Options Exercise $119K +113K $1.06 113K Jun 10, 2024 Direct
transaction GERN Common Stock Options Exercise $21.2K +20K $1.06 20K Jun 10, 2024 Direct
transaction GERN Common Stock Options Exercise $201K +155K $1.30 155K Jun 10, 2024 Direct
transaction GERN Common Stock Sale -$1.33M -288K -100% $4.63 0 Jun 10, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GERN Stock Option (right to buy) Options Exercise $0 -113K -56.25% $0.00 87.5K Jun 10, 2024 Common Stock 113K $1.06 Direct F2
transaction GERN Stock Option (right to buy) Options Exercise $0 -20K -100% $0.00* 0 Jun 10, 2024 Common Stock 20K $1.06 Direct F3
transaction GERN Stock Option (right to buy) Options Exercise $0 -155K -100% $0.00* 0 Jun 10, 2024 Common Stock 155K $1.30 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.52 to $4.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 This option vests in a series of 48 consecutive equal monthly installments commencing February 16, 2022 (of which 112,500 shares were vested as of the exercise date), provided the optionee continues to provide services to the Company.
F3 Option fully vested.